News
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
04 Dec 2025
Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development
Drug delivery challenges include frequent dosing, nighttime administration, and site-specific absorption needs. Controlled and modified-release technologies help improve bioavailability, compliance, a...
Quantitative Clinical Pharmacology (QCP)
API Form and Solid-State Research
Crystal Pharmatech employs an integrated approach to identify and develop the best crystal form for your small molecules through effective screening and rigorous assessments.
Crystallization Development
The aim of a crystallization process development is to find a crystallization process which can stable produce the optimal solid form with all desired properties such as particle size, particle shape,...
Mini-tablet
Pediatric medication is a long-standing unmet clinical need in China. Taking medicine by breaking, guessing on dosage, and lack of special medicines are the main chaos in pediatric medication. From the perspective of physiology and pharmacology, they are not just "miniature versions" of adult drugs, and corresponding changes in dosage form, dosage, and administration form are required.
Case Study 4: Gatifloxacin - Crystalline Form Changes With A Licensed Compound
Gatifloxacin (also known as AM-1155, CG5501, and BMS-206584) has been established as a fluoroquinoline broad-spectrum antibiotic (Fukuda et al. 1998) (Fig. 10). It was originally discovered by Kyorin ...
Crystal Formulation Services successfully passed the dual certification of GMP and GDP conducted by SGS
Recently, Crystal Formulation Services (CFS) successfully obtained dual certification in Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP) from SGS, an internationally recognize...
Subscribe to be the first to get the updates!